September 28, 2023, marked a significant milestone, as HJF Medical Research International Ltd/Gte. (HJFMRI Ltd/Gte.) celebrated the grand opening of its new office in Abuja, Nigeria. The new facility named, the Health Innovations Centre (HIC) is situated in the heart of the Federal Capital Territory (FCT).
Deborah is one of the oldest stories of PEPFAR’s impact in Kenya and is a true testament to the purpose and mission of PEPFAR. More than 20 years ago, Deborah was diagnosed with HIV. She says, “I stayed home for a long time, thinking that I wished the earth could open up and swallow me.”
A new study led by the U.S. Military HIV Research Program (MHRP) has shown that active HIV reservoir that persists even during suppressive antiretroviral therapy (ART) is correlated with increased HIV-specific CD8+ T cell immune response, but prevents them from becoming fully functional. This suggests that strategies targeting the active HIV reservoir hold promise for functional “cure” therapies to bring about long-term HIV remission. Findings were published this week in Cell Host & Microbe.
MHRP in Nigeria, known locally as the Walter Reed Program-Nigeria (WRP-N), in partnership with the Nigeria Ministry of Defence Health Implementation Programme (NMODHIP), conducted a 3-day cervical cancer screening training for 28 healthcare professionals in April.
Dr. Trevor Crowell, a senior HJF clinical investigator with the U.S. Military HIV Research Program (MHRP) was awarded a three-year NIH R01 grant to leverage four MHRP cohorts to apply advanced machine learning analytic techniques to investigate COVID-19 vaccine uptake and impact on HIV and neurobehavioral outcomes.
